WBB Securities Reiterates Strong-Buy Rating for Marker Therapeutics (NASDAQ:MRKR)
Marker Therapeutics (NASDAQ:MRKR – Get Free Report)‘s stock had its “strong-buy” rating reissued by investment analysts at WBB Securities in a note issued to investors on Tuesday,Benzinga reports. They presently have a $12.50 price objective on the stock. MRKR has been the subject of several other research reports. Canaccord Genuity Group assumed coverage on Marker […]
Marker Therapeutics (NASDAQ:MRKR – Get Free Report)‘s stock had its “strong-buy” rating reissued by investment analysts at WBB Securities in a note issued to investors on Tuesday,Benzinga reports. They presently have a $12.50 price objective on the stock. MRKR has been the subject of several other research reports. Canaccord Genuity Group assumed coverage on Marker […]
